The suppression of nuclear translocation of β-catenin into gastric cells along with the expression of the β-catenin target survival genes c-myc and cyclin D1 along with induction of apoptosis has recently been implicated as a potential mechanism of anti-cancer therapy [95]. This evidence concerns the gene CCND1 and cancer.